Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CRL

Charles River Laboratories (CRL)

Charles River Laboratories International Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:CRL
DateTimeSourceHeadlineSymbolCompany
17/09/202422:00Business WireCharles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience ResearchNYSE:CRLCharles River Laboratories International Inc
04/09/202423:21PR Newswire (US)Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in NeuroscienceNYSE:CRLCharles River Laboratories International Inc
04/09/202422:00Business WireCharles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in NeuroscienceNYSE:CRLCharles River Laboratories International Inc
04/09/202406:30Business WireCharles River Laboratories to Present at Baird and Morgan Stanley ConferencesNYSE:CRLCharles River Laboratories International Inc
14/08/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
13/08/202406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
09/08/202403:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
07/08/202423:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CRLCharles River Laboratories International Inc
07/08/202421:21Edgar (US Regulatory)Form 8-K - Current reportNYSE:CRLCharles River Laboratories International Inc
07/08/202421:00Business WireCharles River Laboratories Announces Second-Quarter 2024 ResultsNYSE:CRLCharles River Laboratories International Inc
06/08/202406:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
02/08/202406:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:CRLCharles River Laboratories International Inc
30/07/202422:00Business WireCharles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy DevelopmentNYSE:CRLCharles River Laboratories International Inc
24/07/202422:00Business WireCharles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug DiscoveryNYSE:CRLCharles River Laboratories International Inc
17/07/202406:30Business WireCharles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference CallNYSE:CRLCharles River Laboratories International Inc
08/07/202422:00Business WireCharles River to Perform Plasmid Manufacturing for AAVantgardeNYSE:CRLCharles River Laboratories International Inc
25/06/202422:00Business WireCharles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical CampusNYSE:CRLCharles River Laboratories International Inc
17/06/202422:00Business WireCharles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell TherapyNYSE:CRLCharles River Laboratories International Inc
11/06/202422:00Business WireCharles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research AlternativesNYSE:CRLCharles River Laboratories International Inc
06/06/202422:00Business WireCharles River Laboratories Expands Access to CRADL® Contract Vivarium Space in SomervilleNYSE:CRLCharles River Laboratories International Inc
05/06/202406:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
05/06/202406:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
05/06/202406:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
05/06/202406:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
05/06/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
05/06/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
04/06/202422:00Business WireCharles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in ResearchNYSE:CRLCharles River Laboratories International Inc
04/06/202406:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
03/06/202422:00Business WireCharles River Laboratories to Present at William Blair and Jefferies ConferencesNYSE:CRLCharles River Laboratories International Inc
01/06/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CRLCharles River Laboratories International Inc
 Showing the most relevant articles for your search:NYSE:CRL